Assessing Feasibility of Participant Recruitment from the Regenerative Medicine Consultation Service (RMCS) Practice Database

Overview

About this study

The purpose of this study is to determine the receptivity of the Mayo Clinic’s Regenerative Medicine Consultation Service (RMCS) patients to participating in future research and sharing their ongoing experiences engaging in stem cell therapies (SCTs).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Patient(s) who have called in RMCS in 2018.
Patient(s) who have discussed the potential of considering an unapproved SCT.
Gender.

Exclusion Criteria:

Children.
Deceased patients.
Patients previously dismissed from Mayo Clinic’s care will not be included in the study.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Zubin Master, Ph.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Zubin Master, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials